PDMI - Paradigm Medical Announces Plans to Release

Paradigm Medical Announces Plans to Release Its New Corneal Topographer, the Paravue, in the United States Market





SALT LAKE CITY, UT -- (Marketwire) -- 06/01/09 -- Paradigm Medical Industries, Inc.

(OTCBB: PDMI) announced today that the Company will soon begin to introduce the first of its four new ophthalmic diagnostic devices, the Paravue, during the remainder of 2009. The Paravue is a sophisticated topographer utilizing Placido Disk Technology and an advanced software to provide accurate and detailed analysis of the anterior corneal surface.




Corneal topography -- also known as videokeratography or corneal mapping -- represents a significant advance in the measurement of the corneal curvature. Most corneal topographers evaluate 8,000 to 10,000 specific points across the entire corneal surface. By contrast, the Paravue processes more than 100,000 points. It also offers corneal wave front analysis with 2, 3 or 4 maps available for comparison.





The Paravue provides both a qualitative and quantitative evaluation of corneal curvature. It does so by utilizing a big placido disk with 24 concentric rings, which project onto the cornea to create a virtual image.

The device compares this image to the target size, and the computer then calculates the corneal curvature. Advanced features including advanced rings editing, variable scales, refractive power map and more make the Paravue a valuable tool in the optometric and ophthalmic clinics.




"The addition of the Paravue to our existing ophthalmic product line fills an important segment that was missing," said Paradigm Medical President, Stephen Davis. "We are excited to offer not just another topographer, but one with many impressive features and incredibly friendly software that provides ease of use, flexible mapping and accuracy."



About Paradigm Medical Industries, Inc.




Headquartered in Salt Lake City, UT, Paradigm Medical Industries, Inc. is a medical device company that develops, manufactures and distributes cutting edge, new innovative products in the diagnostic ultrasound and early glaucoma detection markets. Paradigm has the only patented technology utilizing photon laser for cataract removal. The Company is poised to capture a niche market within the Glaucoma and ultrasound microscopy fields. Paradigm Medical Industries markets its products to ophthalmologists, optometrists, universities, and clinics throughout the United States, as well as internationally.




For more information, please visit: www.paradigm-medical.com



This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.


Contact:

Paradigm Medical Industries, Inc.

Stephen Davis

President

801-977-8970

www.paradigm-medical.com